Low free and bioavailable testosterone levels may predict pathologicallyproven high-risk prostate cancer: a prospective, clinical trial
TURKISH JOURNAL OF UROLOGY, cilt.43, sa.3, ss.289-296, 2017 (ESCI, Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 43 Sayı: 3
- Basım Tarihi: 2017
- Doi Numarası: 10.5152/tud.2017.35467
- Dergi Adı: TURKISH JOURNAL OF UROLOGY
- Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.289-296
- Anahtar Kelimeler: Prostate cancer, prostate-specific antigen, radical prostatectomy, testosterone, transrectal prostate biopsy, LOW SERUM TESTOSTERONE, REPLACEMENT THERAPY, STAGE, MEN, HYPOGONADISM, PROGNOSIS, DISEASE
- İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır
Özet
Objective: To determine the predictive value of free and bioavailable testosterone levels on the detection of high-grade prostate cancer proven by histopathological examination of transrectal prostate biopsy specimens.